Cellectis S.A. Stock Other OTC
Equities
CMVLF
FR0010425595
Biotechnology & Medical Research
Sales 2024 * | 16.19M 17.53M 23.89M | Sales 2025 * | 70.57M 76.42M 104M | Capitalization | 195M 211M 287M |
---|---|---|---|---|---|
Net income 2024 * | -74M -80.13M -109M | Net income 2025 * | -71M -76.88M -105M | EV / Sales 2024 * | 12 x |
Net cash position 2024 * | 573K 620K 846K | Net cash position 2025 * | 180M 195M 265M | EV / Sales 2025 * | 0.21 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Cellectis S.A.
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 99-12-19 |
André Choulika
FOU | Founder | 59 | 99-12-19 |
Arthur Stril
DFI | Director of Finance/CFO | 35 | 18-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 20-11-04 | |
André Choulika
FOU | Founder | 59 | 99-12-19 |
David Sourdive
FOU | Founder | 57 | 99-12-19 |
1st Jan change | Capi. | |
---|---|---|
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+47.07% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |